An official website of the United States government
Funding Opportunities Specific to COVID-19
This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
On This Page:
Active Funding Opportunities
| Title | Notice Number | Organization(s) | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional) | PAR-25-115 | NINDS, NIMH, OD | Oct 17, 2024 | Nov 17, 2025 | R21 |
| Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional) | PAR-24-231 | NIMHD | Jun 10, 2024 | Jan 08, 2027 | R01 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) | PA-24-201 | NIH, NIAID, NIAMS, NIDA, NIEHS, NIMHD | Apr 18, 2024 | Apr 19, 2027 | 333 |
| Notice of Special Interest (NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health Equity | NOT-HL-23-110 | NHLBI, NCI, NIDCR, NIEHS, NIMH, NIMHD, NINR, OBSSR, ODP, ORWH | Nov 28, 2023 | Jan 08, 2027 | R01, R34, R21, UG3/UH3, K01, R03, P01, P50, K08, K23 |
| Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research | NOT-MH-23-240 | NIMH | Jun 02, 2023 | Apr 02, 2026 | 333 |
| Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities | NOT-MD-23-008 | NIMHD, NCI, NIAMS, NIDCR, OBSSR, ODP, ORWH, SGMRO | Mar 31, 2023 | Jun 06, 2026 | R01, R21 |
| Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) | NOT-DE-23-004 | NIDCR | Mar 08, 2023 | May 08, 2026 | R21, R01, UG3/UH3 |
| Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy | NOT-HL-23-080 | NHLBI | Feb 22, 2023 | Jul 06, 2025 | R01 |
| Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes | NOT-DA-23-008 | NIDA, NCCIH, NIA, NIAAA | Aug 03, 2022 | Sep 08, 2025 | R61/R33 |
| Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01) | NOT-HL-22-030 | NHLBI | Jul 05, 2022 | Sep 08, 2025 | R01 |
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) | PAR-22-138 | NIMH, NIAAA, NIEHS, ORWH | Mar 15, 2022 | Jan 08, 2025 | R21 |
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) | PAR-22-137 | NIMH, NIAAA, NIEHS, ORWH | Mar 15, 2022 | Jan 08, 2025 | R01 |
| Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups | NOT-HL-22-010 | NHLBI | Jan 31, 2022 | May 08, 2025 | R01 |
| Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research | NOT-MH-22-100 | NIMH | Jan 19, 2022 | Jan 08, 2025 | R21, R34, R01 |
| Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research | NOT-MH-22-100 | NIMH | Jan 19, 2022 | Jan 08, 2025 | R21, R34, R01 |
| Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection | NOT-HL-22-004 | NHLBI, NICHD, NIAID | Dec 21, 2021 | Sep 08, 2025 | R01, R21 |
Expired Funding Opportunities
| Title | Notice Number | Organization(s) | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) | RFA-HD-25-009 | NICHD, NIMH | Apr 24, 2024 | Jul 25, 2024 | R21 |
| Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) | PAR-24-203 | NINDS, NIA | Apr 12, 2024 | Oct 05, 2024 | R01 |
| 2024 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2024-1 Now Available | NOT-AI-24-014 | NIAID | Dec 22, 2023 | N/A | |
| Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) | NOT-OD-24-026 | OD, NIA, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIMH, NIMHD, NLM, ORWH | Nov 16, 2023 | Jul 16, 2024 | R21 |
| Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) | RFA-MD-24-001 | NIMHD | Oct 17, 2023 | Dec 19, 2023 | U54 |
| Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed) | RFA-NS-24-025 | NINDS | Jun 26, 2023 | Nov 09, 2023 | R03 |
| Emergency Award: RADx-UP Dissemination and Implementation (D and I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional) | RFA-OD-23-051 | OD, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NLM, OBSSR, SGMRO | May 02, 2023 | Jul 11, 2023 | R01 |
| Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed) | RFA-OD-23-050 | OD, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NLM, OBSSR | May 02, 2023 | Jul 04, 2023 | R21 |
| Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) | RFA-NS-23-022 | NINDS, NIA, NIMH | Mar 28, 2023 | Feb 03, 2024 | R21 |
| Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) | RFA-NS-23-021 | NINDS, NIA, NIMH | Mar 28, 2023 | Feb 03, 2024 | R01 |
| Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed) | RFA-AG-24-010 | NIA | Mar 14, 2023 | Jul 03, 2023 | U01 |
| Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | RFA-NR-23-003 | NINR, NIMH, NIMHD, ODP | Feb 27, 2023 | May 02, 2023 | R01 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) | NOT-NS-23-068 | NINDS, NIA, NIMH | Feb 23, 2023 | N/A | |
| Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) | NOT-NS-23-069 | NINDS, NIA, NIMH | Feb 23, 2023 | N/A | |
| Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional) | NOT-OD-23-046 | ORWH, NCI, NIA, NIAID, NICHD, NIDA, NIMHD, NLM, SGMRO | Jan 24, 2023 | Mar 01, 2023 | 333 |
| Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional) | RFA-MD-23-001 | NIMHD | Jan 03, 2023 | Mar 02, 2023 | U54 |
| Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases | NOT-AR-23-008 | NIAMS | Dec 29, 2022 | Jan 08, 2024 | R01, R21 |
| Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) | NOT-MD-23-001 | NIMHD, NIDA, ORWH | Dec 20, 2022 | Mar 03, 2023 | 333 |
| Notice of Special Interest (NOSI): Research Supplements to Promote Data Science Workforce Diversity to Reveal Scientific Insights of COVID-19 Testing Technologies (Admin Supp Clinical Trial Not Allowed) | NOT-OD-23-041 | OD, NIA, NICHD, NIDA, NIDCR, NIMH, NIMHD, NINR, NLM | Dec 19, 2022 | Feb 20, 2023 | 333 |
| Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) | NOT-OD-23-040 | OD, NIA, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIMH, NIMHD, NLM, ORWH | Dec 19, 2022 | Jan 05, 2024 | R21 |
| Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional) | NOT-OD-23-029 | ORWH, NCI, NIA, NIAID, NIDA, NIMHD, NLM, SGMRO | Dec 05, 2022 | Mar 01, 2023 | 333 |
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) | RFA-HD-24-006 | NICHD, NIMH | Nov 22, 2022 | Mar 30, 2023 | R21 |
| Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) | RFA-DA-24-002 | NIDA | Nov 15, 2022 | Mar 24, 2023 | R61/R33 |
| Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) | RFA-AI-22-069 | NIAID | Nov 14, 2022 | Apr 08, 2023 | U19 |
| Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-22-208 | ORWH, NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, PN, SGMRO | Sep 07, 2022 | Feb 01, 2023 | 333 |
| Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3) | RFA-OD-22-019 | OD, NCATS, NCCIH, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OBSSR, ODP, ORWH | Aug 30, 2022 | Nov 22, 2022 | UG3/UH3 |
| Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) | RFA-OD-22-018 | OD, NCATS, NCCIH, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OBSSR, ODP, ORWH | Aug 30, 2022 | Nov 22, 2022 | UG3/UH3 |
| Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed) | RFA-AI-22-055 | NIAID | Aug 22, 2022 | Jan 14, 2023 | U01 |
| Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) | RFA-DK-22-016 | NIDDK | Jul 13, 2022 | Dec 21, 2022 | U01 |
| Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) | PAR-22-203 | NIBIB, FIC, NCCIH, NCI, NHLBI, NIAID, NIDA | Jul 13, 2022 | Jan 08, 2023 | U54 |
| Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) | NOT-MD-22-022 | NIMHD | Jun 30, 2022 | Aug 01, 2022 | 333 |
| Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs | NOT-NS-23-001 | NINDS, NIA | Jun 21, 2022 | Aug 12, 2022 | 333 |
| Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity | NOT-OD-22-135 | ONR, FIC, NCI, NHLBI, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NIMHD, NINR, OAR, OBSSR, ODP, ODS, PN, ORWH | Jun 21, 2022 | Nov 29, 2024 | R01, 333, R21, K01, R34, R33, R61/R33, UG3/UH3, K43 |
| Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) | RFA-DA-23-052 | NIDA | Jun 13, 2022 | Aug 11, 2022 | U24 |
| NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) | RFA-HD-23-026 | NICHD | May 23, 2022 | Sep 09, 2022 | P01 |
| Notice of Special Interest: Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data | NOT-PM-22-002 | OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OAR, OBSSR, ODSS, ORWH, RM, SGMRO | May 20, 2022 | Jul 06, 2022 | 333 |
| Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) | PAR-22-167 | NCATS, NIAMS, NICHD, NIDCR, NIGMS, NIMHD, OBSSR, ORWH | May 09, 2022 | Oct 18, 2024 | UG3/UH3 |
| NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data Coordinating Center (U24 Clinical Trial Optional) | RFA-HD-23-017 | NICHD | May 06, 2022 | Aug 12, 2022 | U24 |
| Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) | RFA-AG-23-024 | NIA | May 06, 2022 | Oct 21, 2022 | R01 |
| Notice of Special Interest (NOSI): IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity | NOT-OD-22-125 | OD | May 05, 2022 | Jul 17, 2022 | R01, R03, R21 |
| Notice of Special Interest (NOSI): Administrative Supplements to Support "All of US" and Health Disparities-Related Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) | NOT-MD-22-015 | NIMHD | May 03, 2022 | Jun 28, 2022 | 333 |
| Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA | NOT-AA-22-012 | NIAAA | Apr 29, 2022 | Mar 06, 2024 | R01, R03, R21, K99/R00 |
| Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities | NOT-HD-22-003 | NICHD, NIAAA, NIDA, NINDS, OBSSR, ORWH | Apr 19, 2022 | Jun 06, 2024 | 333 |
| Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed) | RFA-OD-22-011 | OD, NIA, NIAMS, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM | Apr 06, 2022 | Jun 01, 2022 | U24 |
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities | NOT-ES-22-005 | NIEHS | Mar 29, 2022 | Jun 07, 2022 | 333 |
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities | NOT-ES-22-005 | NIEHS | Mar 29, 2022 | Jun 07, 2022 | 333 |
| Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities | NOT-HD-22-002 | NICHD, NIDA, NIEHS, NINDS, OBSSR, ORWH | Mar 28, 2022 | Jun 06, 2024 | R01, R21 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) | NOT-DK-22-018 | NIDDK | Mar 23, 2022 | N/A | |
| Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional) | RFA-MD-22-008 | NIMHD, NCI | Mar 22, 2022 | Nov 14, 2022 | R01 |
| Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) | RFA-OD-22-005 | OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR | Feb 17, 2022 | May 03, 2022 | U01 |
| Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) | RFA-OD-22-006 | OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR | Feb 17, 2022 | May 03, 2022 | U01 |
| Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment | NOT-EY-22-010 | NEI | Feb 04, 2022 | Mar 09, 2024 | R41/R42, R15, 333, R01, R43/R44, R21 |
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) | PAR-22-112 | NIMH | Jan 31, 2022 | Dec 24, 2022 | R01 |
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) | PAR-22-112 | NIMH | Jan 31, 2022 | Dec 24, 2022 | R01 |
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) | PAR-22-113 | NIMH | Jan 31, 2022 | Dec 24, 2022 | R01 |
| Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | RFA-NR-22-001 | NINR, NIDA, NIMH, NIMHD, OBSSR, ODP | Jan 25, 2022 | Apr 08, 2022 | R01 |
| HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) | RFA-DE-22-011 | NIDCR, NCATS, NCCIH, NCI, NIA, NIAMS, NICHD | Jan 21, 2022 | Apr 01, 2022 | R21 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies | NOT-GM-22-026 | NIGMS | Jan 21, 2022 | Mar 22, 2022 | 333 |
| RESCINDED - Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy | NOT-HL-23-003 | NHLBI | Jan 21, 2022 | Jul 06, 2022 | R01 |
| Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases | NOT-AR-22-012 | NIAMS | Dec 28, 2021 | Jan 08, 2023 | R21, R01 |
| RESCINDED - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities | NOT-MD-22-006 | NIMHD, ODP, NIDA, NIAID, SGMRO, NIMH, ORWH, NINR, NCI, NIDCR, OBSSR | Dec 21, 2021 | Jan 08, 2023 | R01 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | NOT-NR-22-004 | NINR, NIMH, ODP, OBSSR, NIDA, NIMHD | Dec 17, 2021 | N/A | |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection | NOT-OD-22-038 | OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, ORIP, ODP, ORWH | Dec 07, 2021 | Jan 25, 2022 | 333 |
| Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA | NOT-AA-22-002 | NIAAA | Dec 02, 2021 | May 08, 2024 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional) | NOT-OD-22-030 | ORWH, NIDA, NEI, NIDCD, NIEHS, NHGRI, NIMH, NIAID, NINR, NICHD, NHLBI, NCCIH, NIAAA, SGMRO, NCATS, NIDCR, NIAMS, ORIP, NIDDK, NIBIB, NIA | Dec 02, 2021 | Jan 27, 2023 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) | NOT-MD-22-001 | NIMHD, NIDA | Oct 25, 2021 | Feb 02, 2022 | 333 |
| Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) | RFA-HD-22-009 | NICHD | Aug 25, 2021 | Nov 30, 2021 | P01 |
| Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations | NOT-MH-21-330 | NIMH, NIDCD, NIA, NIDCR, NIMHD, ORWH, NICHD, NEI, ODP, SGMRO, NIDA, OBSSR, NIAAA, NINR, NCCIH | Aug 20, 2021 | Sep 08, 2024 | R01, UG3/UH3 |
| Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations | NOT-MH-21-330 | NIMH, NCCIH, NINR, NIAAA, OBSSR, NIDA, SGMRO, ODP, NEI, NICHD, ORWH, NIMHD, NIDCR, NIA, NIDCD | Aug 20, 2021 | Sep 08, 2024 | R01, UG3/UH3 |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) | PAR-21-276 | NIAID | Jul 16, 2021 | Jul 16, 2022 | S10 |
| Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 | NOT-HD-21-037 | NICHD | Jul 02, 2021 | May 08, 2022 | 333 |
| Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities | NOT-HD-21-038 | NICHD | Jun 28, 2021 | May 08, 2024 | R03, R21 |
| Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide | NOT-AI-21-057 | NIAID, NIMH, NIDA | Jun 25, 2021 | May 08, 2024 | R01, R21 |
| Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) | NOT-MD-21-020 | NIMHD | May 27, 2021 | Jul 16, 2021 | 333 |
| Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) | RFA-DA-22-001 | NIDA | Apr 27, 2021 | Aug 14, 2021 | R43/R44 |
| Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | NOT-DA-21-041 | NIDA | Apr 15, 2021 | Mar 31, 2022 | 333 |
| Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) | RFA-OD-21-009 | NIH, NLM, NIAID, ECHO, NICHD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NIA, NIAAA, NIDCD, NIDA, NIMHD, OBSSR, ODP, ORWH, SGMRO, THRO, NIBIB | Apr 13, 2021 | Jul 08, 2021 | U01 |
| Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake | NOT-OD-21-101 | NIH, NIMH, NIDDK, NICHD, NCI, NCATS, NCCIH, NHLBI, NIEHS, NIGMS, NINR, NIA, NIAAA, NIDA, NIMHD, NLM, NIAID | Apr 13, 2021 | May 04, 2021 | 333 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional) | NOT-OD-21-103 | NIH, NIDCD, ECHO, NICHD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAID, NIAMS, NIBIB, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NIA, NIAAA, NIDA, NIMHD, NLM, OBSSR, ODP, ORWH, SGMRO, THRO, NIDDK | Apr 13, 2021 | May 25, 2021 | U01 |
| Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) | RFA-OD-21-008 | NIH, NIBIB, NIDDK, NIEHS, NIMH, NINDS, NINR, NIA, NIAAA, NIDCD, NIDA, NIMHD, NLM, OBSSR, ODP, SGMRO, THRO, NIDCR, NHLBI, ECHO, NICHD, NCI, NCATS, NCCIH, NEI, NHGRI, NIAID, NIAMS, NIGMS, ORWH | Apr 13, 2021 | Jul 08, 2021 | U01 |
| Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) | RFA-AG-21-035 | NIA, ORWH, OBSSR | Apr 08, 2021 | Jun 10, 2021 | U24 |
| Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) | PAR-21-213 | NIA, NEI, NIAAA, NIDA, NIMH, NIMHD, NINR, OBSSR, ORWH | Apr 06, 2021 | Nov 09, 2021 | U01 |
| Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries | NOT-TW-21-004 | FIC | Mar 23, 2021 | May 15, 2021 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards | NOT-TW-21-003 | FIC | Mar 23, 2021 | May 15, 2021 | 333 |
| Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II) | NOT-OD-21-064 | NIH, ORWH | Mar 22, 2021 | N/A | |
| Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations | NOT-NS-21-037 | NINDS | Mar 15, 2021 | May 06, 2021 | 333 |
| Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations | NOT-NS-21-037 | NINDS | Mar 15, 2021 | May 06, 2021 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy | NOT-GM-21-032 | NIGMS | Mar 10, 2021 | May 01, 2021 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy | NOT-GM-21-032 | NIGMS | Mar 10, 2021 | May 01, 2021 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19 | NOT-OD-21-071 | NIH | Mar 05, 2021 | Apr 14, 2021 | 333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy | NOT-GM-21-021 | NIGMS, SGMRO | Mar 01, 2021 | May 01, 2021 | 333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy | NOT-GM-21-021 | NIGMS, SGMRO | Mar 01, 2021 | May 01, 2021 | 333 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | NOT-TR-21-022 | NCATS | Feb 26, 2021 | Jun 22, 2023 | 333 |
| Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration | NOT-AG-21-016 | NIA | Feb 26, 2021 | May 08, 2023 | R01, R21, R03 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-21-019 | NIGMS | Feb 25, 2021 | Dec 16, 2021 | 333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-21-019 | NIGMS | Feb 25, 2021 | Dec 16, 2021 | 333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies | NOT-GM-21-031 | NIGMS | Feb 18, 2021 | Apr 01, 2021 | 333 |
| Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders | NOT-DA-21-019 | NIDA | Feb 10, 2021 | Sep 08, 2024 | R01, R03, R21 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) | RFA-AA-21-003 | NIAAA | Feb 05, 2021 | Aug 18, 2021 | R03 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) | RFA-AA-21-003 | NIAAA | Feb 05, 2021 | Aug 18, 2021 | R03 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) | RFA-AA-21-002 | NIAAA | Feb 05, 2021 | Aug 18, 2021 | R01 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) | RFA-AA-21-002 | NIAAA | Feb 05, 2021 | Aug 18, 2021 | R01 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) | RFA-AA-21-004 | NIAAA | Feb 05, 2021 | Aug 18, 2021 | R21 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) | RFA-AA-21-004 | NIAAA | Feb 05, 2021 | Aug 18, 2021 | R21 |
| Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 | NOT-DA-21-017 | NIDA | Feb 04, 2021 | Sep 08, 2024 | R01, R03, R21 |
| Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) | NOT-AI-21-008 | NIAID | Feb 04, 2021 | Jan 08, 2023 | R01, R21 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation | NOT-MD-21-012 | NIMHD | Feb 04, 2021 | May 04, 2021 | 333 |
| Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders | NOT-DA-21-018 | NIDA | Feb 03, 2021 | Sep 08, 2024 | R01, R03, R21 |
| Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control | NOT-CA-21-033 | NCI | Feb 03, 2021 | Apr 01, 2021 | 333 |
| Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | NOT-TR-21-017 | NCATS | Feb 03, 2021 | Aug 17, 2024 | 333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) | NOT-AA-21-003 | NIAAA | Jan 27, 2021 | Feb 28, 2021 | |
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) | NOT-AA-21-003 | NIAAA | Jan 27, 2021 | Feb 28, 2021 | |
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed) | NOT-AA-21-002 | NIAAA | Jan 27, 2021 | Feb 03, 2021 | |
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) | NOT-AA-21-001 | NIAAA | Jan 27, 2021 | Feb 28, 2021 | |
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) | NOT-AA-21-001 | NIAAA | Jan 27, 2021 | Feb 28, 2021 | |
| Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) | NOT-DE-21-001 | NIDCR | Jan 26, 2021 | May 08, 2023 | R01, R21 |
| Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) | NOT-AG-21-015 | NIA | Jan 26, 2021 | Sep 10, 2021 | R01, R03, R21, U19, P01, R21/R33 |
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection | NOT-DA-21-011 | NIDA | Jan 26, 2021 | Sep 08, 2024 | R01, R03, R21 |
| Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) | RFA-AI-20-078 | NIAID, NICHD, NIEHS | Jan 12, 2021 | Jun 19, 2021 | U19 |
| Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) | RFA-AI-20-077 | NIAID, NICHD, NIEHS | Jan 12, 2021 | Jun 19, 2021 | U01 |
| Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases | NOT-AR-21-012 | NIAMS | Jan 05, 2021 | Nov 19, 2021 | R01, R21 |
| Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research | NOT-MH-21-120 | NIMH | Dec 23, 2020 | Jun 02, 2023 | 333 |
| RESCINDED - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities | NOT-MD-21-008 | NIMHD, NCI, NHLBI, NIAAA, NIAID, NIAMS, NIDCR, NIMH, NINR, OBSSR, ODP, ORWH | Dec 17, 2020 | Jan 08, 2022 | R01 |
| Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs | NOT-TR-21-011 | NCATS | Dec 17, 2020 | Jun 02, 2021 | 333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts | NOT-HG-21-020 | NHGRI | Dec 10, 2020 | Jan 16, 2021 | 333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities | NOT-MD-21-007 | NIMHD | Dec 07, 2020 | Dec 31, 2020 | |
| Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) | NOT-OD-21-035 | NIH, NIDCR, NHLBI | Nov 25, 2020 | Dec 05, 2020 | 333 |
| Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) | NOT-OD-21-020 | NIH, NLM, NIEHS, NIAMS, NIDCR, OBSSR, NIGMS, NHLBI, NCI, NIAAA, NINR, NCATS, ORWH, NHGRI, FIC, NCCIH, NIMH, THRO, NIDA, NINDS, NEI, NIMHD, NIAID, NIA, FDA, NIBIB, NIDCD, NICHD, NIDDK | Nov 17, 2020 | Mar 05, 2021 | 333 |
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities | NOT-ES-21-002 | NIEHS | Nov 17, 2020 | Dec 30, 2020 | 333 |
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities | NOT-ES-21-002 | NIEHS | Nov 17, 2020 | Dec 30, 2020 | 333 |
| Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects | NOT-AI-21-002 | NIAID | Nov 10, 2020 | Jun 12, 2021 | P01 |
| RESCINDED - Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection | NOT-DA-20-084 | NIDA | Oct 27, 2020 | Jan 26, 2021 | R01, R03, R21 |
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | NOT-TR-21-006 | NCATS | Oct 23, 2020 | Mar 17, 2021 | UH2, U34, U01 |
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | NOT-TR-21-006 | NCATS | Oct 23, 2020 | Mar 17, 2021 | UH2, U34, U01 |
| Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) | NOT-HL-20-814 | NHLBI | Sep 15, 2020 | Jul 06, 2024 | R01 |
| Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 | NOT-AI-20-065 | NIAID | Aug 13, 2020 | Mar 15, 2021 | U01 |
| Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities | NOT-MD-20-025 | NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS | Aug 13, 2020 | May 08, 2023 | R01 |
| Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) | RFA-OD-20-023 | NIH, FIC, NCATS, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD | Aug 06, 2020 | Oct 01, 2020 | R61/R33 |
| Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) | RFA-OD-20-022 | NIH, NIA, NIDCD, ORWH, NICHD, NLM, NINR, NINDS, NIDCR | Aug 06, 2020 | Sep 16, 2020 | U01 |
| Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) | RFA-OD-20-021 | NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR | Aug 06, 2020 | Sep 19, 2020 | R42 |
| Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) | RFA-OD-20-020 | NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR | Aug 06, 2020 | Sep 19, 2020 | R44 |
| Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) | RFA-OD-20-019 | NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDA | Aug 06, 2020 | Oct 01, 2020 | U24 |
| Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) | RFA-OD-20-018 | NIH, NIA, NHGRI, NCI, RM, NCATS, NHLBI, NIDCR, NIDA | Aug 06, 2020 | Sep 19, 2020 | U18 |
| Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) | RFA-OD-20-018 | NIH, NIDA, NIDCR, NHLBI, NCATS, RM, NCI, NHGRI, NIA | Aug 06, 2020 | Sep 19, 2020 | U18 |
| Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) | RFA-OD-20-017 | NIH, NIAAA, NIA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR | Aug 06, 2020 | Sep 19, 2020 | U18 |
| Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) | RFA-OD-20-016 | NIH, NIAAA, NIDDK, NIGMS, NIMHD, NLM, NINR, OBSSR, NIDCR, NIDA | Aug 06, 2020 | Oct 01, 2020 | R01 |
| Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) | RFA-OD-20-015 | NIH, NIEHS, NIGMS, NLM, NIDA | Aug 06, 2020 | Sep 16, 2020 | U01 |
| Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) | RFA-OD-20-014 | NIH, NIAAA, NIA, NCCIH, NCI, NICHD | Aug 06, 2020 | Sep 16, 2020 | U01 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool | NOT-OD-20-152 | NIH, NIA, NIDCD, ORWH, NICHD, NINR, NINDS, NIDCR | Aug 06, 2020 | Sep 16, 2020 | 333 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). | NOT-OD-20-159 | NIH, NLM | Aug 06, 2020 | Aug 22, 2020 | 333 |
| Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) | RFA-TR-20-003 | NCATS | Aug 05, 2020 | Jan 24, 2021 | U01 |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) | PAR-20-256 | NIAID | Jul 13, 2020 | Jul 08, 2021 | S10 |
| Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative | NOT-OD-20-144 | NIH, NIDCD | Jul 10, 2020 | Aug 06, 2020 | |
| Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) | RFA-DK-20-021 | NIDDK | Jul 10, 2020 | Dec 17, 2020 | R01 |
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | NOT-AI-20-059 | NIAID | Jul 06, 2020 | Jul 02, 2021 | 333 |
| Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) | NOT-CA-20-082 | NCI | Jul 06, 2020 | Aug 15, 2020 | 333 |
| Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) | PAR-20-243 | NIMH, NCCIH, NEI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIMHD, NINR, OBSSR, ODP, ORWH | Jun 25, 2020 | Mar 03, 2021 | R01 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project | NOT-OD-20-129 | NIH, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, ORIP | Jun 25, 2020 | Jul 13, 2021 | 333 |
| Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers | NOT-CA-20-077 | NCI | Jun 25, 2020 | Jul 31, 2020 | |
| Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) | PAR-20-237 | NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCR | Jun 17, 2020 | Dec 02, 2020 | R01 |
| Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need | NOT-TR-20-029 | NCATS | Jun 15, 2020 | Nov 11, 2020 | 333 |
| NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) | PAR-20-234 | NIA | Jun 15, 2020 | Feb 02, 2021 | R01 |
| Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | NOT-OD-20-121 | NIH, NIDCR, NICHD, NCI, NCATS, NEI, NHLBI, NIAID, NIAMS, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, NIA, NCCIH, ODP | Jun 12, 2020 | Aug 08, 2020 | 333 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | NOT-OD-20-120 | NIH, NIAID, NIBIB, NIDCR, NIMHD, NICHD, NIAMS, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIA, NIDCD, NIDA, ORWH, OBSSR, ODP, NLM, SGMRO, THRO | Jun 12, 2020 | Sep 09, 2020 | 333 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | NOT-OD-20-119 | NIH, NEI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIA, NIAAA, NIDA, NIMHD, ORWH, ODP, NLM, SGMRO, THRO, NIDCD, OBSSR, NICHD, FIC, NCI, NCATS, NCCIH | Jun 12, 2020 | Sep 09, 2020 | 333 |
| Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) | RFA-OD-20-013 | NIH, NCI, NIAMS, NIA, NICHD, FIC, NCATS, NCCIH, NEI, NHLBI, NIBIB, NIDCR, NIEHS, NIGMS, NHGRI, NIMH, NINR, NIDCD, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, ODP | Jun 12, 2020 | Aug 08, 2020 | U24 |
| Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) | RFA-CA-20-038 | NCI, NIAID | Jun 05, 2020 | Jul 23, 2020 | U54 |
| Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) | RFA-CA-20-039 | NCI, NIAID | Jun 05, 2020 | Jul 23, 2020 | U01 |
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations | NOT-MD-20-022 | NIMHD, NCATS, ORWH, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, OBSSR, ODP | Jun 05, 2020 | Dec 30, 2020 | 333 |
| Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 | NOT-MH-20-053 | NIMH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NINR, OBSSR, ODP, ORWH | Jun 05, 2020 | Dec 30, 2020 | 333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) | NOT-MH-20-058 | NIMH, NIAAA, NIA, NCCIH, NIDCD, NICHD, NINR, OBSSR, ODP, NIDCR, NIDA, NEI | Jun 04, 2020 | Jun 26, 2020 | |
| Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders | NOT-DC-20-008 | NIDCD | Jun 04, 2020 | Sep 08, 2022 | R01, R21, R41/R42, R43/R44 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) | NOT-MD-20-023 | NIMHD, NIEHS, NIA, NICHD, ORWH, NIDCD, OBSSR, NIDA, NINR, ODP, NCCIH, NIMH, NIDCR | Jun 03, 2020 | Jun 17, 2020 | |
| Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives | NOT-OD-20-112 | NIH | May 29, 2020 | Jun 26, 2020 | |
| Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research | NOT-OD-20-107 | NIH | May 27, 2020 | Jun 30, 2020 | 333 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) | NOT-AT-20-012 | NCCIH | May 26, 2020 | Aug 18, 2020 | 333 |
| NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) | RFA-RM-20-020 | RMOD | May 21, 2020 | Oct 01, 2020 | R01 |
| NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional) | RFA-RM-20-021 | RMOD | May 21, 2020 | Sep 05, 2020 | DP5 |
| Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | NOT-AI-20-051 | NIAID | May 19, 2020 | Sep 08, 2020 | R03, R43/R44, R41/R42 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence | NOT-CA-20-066 | NCI | May 15, 2020 | Jun 05, 2020 | |
| Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR | NOT-DE-20-022 | NIDCR, ORWH | May 05, 2020 | Nov 03, 2020 | 333 |
| Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network | NOT-DE-20-023 | NIDCR | May 01, 2020 | Nov 03, 2020 | X01 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System | NOT-NS-20-051 | NINDS | Apr 30, 2020 | Apr 15, 2021 | 333 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) | PAR-20-177 | NIAID | Apr 30, 2020 | Aug 14, 2020 | R21 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) | PAR-20-178 | NIAID | Apr 30, 2020 | Aug 14, 2020 | R01 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials | NOT-HL-20-782 | NHLBI | Apr 27, 2020 | Oct 06, 2020 | 333 |
| Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) | NOT-LM-20-011 | NLM | Apr 27, 2020 | Jun 17, 2020 | R21 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | NOT-RM-20-015 | RMOD | Apr 27, 2020 | Jun 20, 2020 | 333 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs | NOT-TR-20-028 | NCATS | Apr 23, 2020 | Nov 11, 2020 | 333 |
| Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA | NOT-AA-20-011 | NIAAA | Apr 16, 2020 | Apr 16, 2021 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) | NOT-LM-20-010 | NLM | Apr 16, 2020 | Jun 02, 2020 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences | NOT-OD-20-097 | OBSSR, NCCIH, NCI, NHGRI, NHLBI, NIAAA, NICHD, NIDDK, NIEHS, NINR, ODP, ORWH | Apr 13, 2020 | Apr 01, 2021 | 333 |
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) | NOT-ES-20-020 | NIEHS | Apr 10, 2020 | May 04, 2021 | 333, R21 |
| Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | NOT-EB-20-007 | NIBIB | Apr 10, 2020 | Aug 29, 2020 | R01, R21, R03 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 | NOT-GM-20-027 | NIGMS | Apr 10, 2020 | May 06, 2020 | 333 |
| NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) | NOT-ES-20-017 | NIEHS | Apr 10, 2020 | Apr 25, 2020 | 333 |
| Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | NOT-EB-20-006 | NIBIB | Apr 10, 2020 | Sep 06, 2020 | R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | NOT-EB-20-008 | NIBIB | Apr 10, 2020 | Aug 29, 2020 | 333 |
| Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 | NOT-NS-20-046 | NINDS | Apr 10, 2020 | May 09, 2020 | 333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission | NOT-DK-20-020 | NIDDK | Apr 09, 2020 | Jun 02, 2020 | 333 |
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities | NOT-MD-20-019 | NIMHD, NIAAA, NIMH, ODP | Apr 09, 2020 | May 01, 2021 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus | NOT-TR-20-017 | NCATS | Apr 09, 2020 | Jan 26, 2022 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus | NOT-MH-20-047 | NIMH, NIAAA, ODP | Apr 09, 2020 | Apr 16, 2021 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus | NOT-TR-20-016 | NCATS | Apr 09, 2020 | Jan 26, 2022 | 333 |
| Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) | NOT-CA-20-043 | NCI | Apr 09, 2020 | Jun 26, 2020 | 333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK | NOT-DK-20-018 | NIDDK | Apr 09, 2020 | Jun 02, 2020 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) | NOT-DC-20-004 | NIDCD | Apr 09, 2020 | Jun 02, 2020 | 333 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) | NOT-AT-20-011 | NCCIH, NIA, NIAAA, ODP | Apr 09, 2020 | Oct 07, 2020 | 333 |
| Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) | NOT-CA-20-042 | NCI | Apr 09, 2020 | Jun 26, 2020 | 333 |
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) | NOT-ES-20-015 | NIEHS | Apr 08, 2020 | May 04, 2021 | 333, R21 |
| Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) | NOT-AG-20-022 | NIAAA, NIMH | Apr 02, 2020 | May 01, 2021 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | NOT-HG-20-030 | NHGRI | Mar 31, 2020 | May 16, 2020 | 333 |
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | NOT-TR-20-012 | NCATS | Mar 27, 2020 | Oct 17, 2020 | UH2, U01, U34 |
| RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | NOT-AI-20-031 | NIAID | Mar 27, 2020 | Apr 05, 2021 | R03, R21, 333, R01, R43/R44, R41/R42 |
| RESCINDED - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) | NOT-ES-20-014 | NIEHS | Mar 27, 2020 | Apr 25, 2020 | 333 |
| RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | NOT-AI-20-034 | NIAID | Mar 25, 2020 | Jul 06, 2020 | 333 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-20-025 | NIGMS | Mar 25, 2020 | Feb 06, 2021 | 333 |
| Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need | NOT-TR-20-011 | NCATS | Mar 24, 2020 | Jul 10, 2021 | 333, U01, R21, U54 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | NOT-DA-20-047 | NIDA | Mar 19, 2020 | Mar 31, 2021 | 333 |
| RESCINDED - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) | NOT-HL-20-757 | NHLBI | Mar 17, 2020 | May 15, 2020 | 333 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) | PA-20-135 | NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC | Mar 10, 2020 | Jun 10, 2023 | 333 |
| RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) | NOT-AI-20-030 | NIAID, NIGMS | Feb 06, 2020 | Apr 08, 2020 | 333 |
| Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-20-048 | ORWH, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | Dec 13, 2019 | Jan 26, 2021 | 333 |
| The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) | RFA-OD-19-029 | ORWH, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIDA, NIDCR, NIEHS, NIMH, NINR | Sep 27, 2019 | Nov 27, 2021 | R01 |
This page last updated on: December 20, 2024
For technical issues E-mail OER Webmaster